None
Quote | Edesa Biotech Inc. (NYSE:EDSA)
Last: | $ |
---|---|
Change Percent: | -0.32% |
Open: | $3.1556 |
Close: | $3.16 |
High: | $3.23 |
Low: | $3.1338 |
Volume: | 23,044 |
Last Trade Date Time: | 02/12/2020 04:42:01 pm |
News | Edesa Biotech Inc. (NYSE:EDSA)
TORONTO, ON / ACCESSWIRE / April 11, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that the company will participate in the 2024 Bloom Burton & Co. Health...
TORONTO, ON / ACCESSWIRE / April 2, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that Edesa management plans to participate in the following upcoming investo...
Message Board Posts | Edesa Biotech Inc. (NYSE:EDSA)
Subject | By | Source | When |
---|---|---|---|
$EDSA: Hey, big THANKS to ya, Capt. S-L!!! | Invest-in-America | investorshub | 01/06/2023 1:51:37 AM |
Hey my brother I feel great that you | subslover | investorshub | 01/06/2023 1:04:59 AM |
$EDSA: Hey, & YOU'RE stock picks, Sir, have | Invest-in-America | investorshub | 01/04/2023 9:10:23 PM |
$2,26 close so that dip last week was | subslover | investorshub | 01/04/2023 9:02:12 PM |
Once the volume picks up, we will have | subslover | investorshub | 01/04/2023 6:57:00 PM |
News, Short Squeeze, Breakout and More Instantly...
Edesa Biotech Inc. Company Name:
EDSA Stock Symbol:
NYSE Market:
TORONTO, ON / ACCESSWIRE / April 11, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that the company will participate in the 2024 Bloom Burton & Co. Health...
TORONTO, ON / ACCESSWIRE / April 2, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that Edesa management plans to participate in the following upcoming investo...
TORONTO, ON / ACCESSWIRE / March 21, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that the company will participate in a Fireside Chat and host one-on-one me...